The 22nd annual North American Cystic Fibrosis Conference registration begins in Orlando, Fla.

More than 3,500 leading cystic fibrosis scientists, doctors and caregivers convened today in Orlando, Fla. for the CF Foundation’s 22nd annual North American Cystic Fibrosis Conference (NACFC).

The group of CF professionals, who have traveled to Orlando from all over the world, will exchange ideas and discuss the latest developments in CF research and care from October 23rd to October 25th.

“No part of the CF story is more important than how our work impacts the life of a patient,” said Robert J. Beall, Ph.D., president and CEO of the CF Foundation. “Let me summarize why we are here this weekend. Emily Schaller, a 26-year old woman with CF recently spoke with Forbes magazine about how the CF Foundation has impacted her life. Her response: “They are the reason I’m alive.” That is what drives us to be here this weekend, and why we will never rest in our quest to cure CF,” said Beall in his welcoming remarks.

President and CEO of the CF Foundation Robert J. Beall, Ph.D. welcomes Rosie Barnes (left), chief executive of the British CF Trust, and Cathleen Morrison, CEO of the Canadian CF Foundation to NACFC.

This year’s NACFC, the largest in its 22-year history, will provide an opportunity for professionals of all disciplines to learn from one another and build important collaborations. Key topics of discussions include:

Advancements in drug discovery and development

The importance of clinical trials

Quality improvement and patient outcomes

The importance of newborn screening

Adult care for an aging CF population

Check back after the conference for detailed information, including expert video interviews, about the important CF topics covered at NACFC.